Journal home
Advance online publication
Current issue
Archive
Press releases
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews Immunology
Nature Medicine
Nature Cell Biology
NI Tutorial: Finding regulatory DNA regions
Signaling Gateway
Immunology & Cell Biology
Mucosal Immunology
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Immunology 6, 1245 - 1252 (2005)
Published online: 13 November 2005; | doi:10.1038/ni1271

The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity

Chen Zhu1, Ana C Anderson1, Anna Schubart1, Huabao Xiong2, Jaime Imitola1, Samia J Khoury1, Xin Xiao Zheng3, Terry B Strom3 & Vijay K Kuchroo1

1  Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

2  Immunobiology Center, Mount Sinai School of Medicine of New York University, New York, New York 10029, USA.

3  Division of Immunology and Transplant Research Center, Beth Israel and Deaconess Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

Correspondence should be addressed to Vijay K Kuchroo vkuchroo@rics.bwh.harvard.edu

Tim-3 is a T helper type 1 (TH1)–specific cell surface molecule that seems to regulate TH1 responses and the induction of peripheral tolerance. However, the identity of the Tim-3 ligand and the mechanism by which this ligand inhibits the function of effector TH1 cells remain unknown. Here we show that galectin-9 is the Tim-3 ligand. Galectin-9-induced intracellular calcium flux, aggregation and death of TH1 cells were Tim-3-dependent in vitro, and administration of galectin-9 in vivo resulted in selective loss of interferon-bold gamma-producing cells and suppression of TH1 autoimmunity. These data suggest that the Tim-3–galectin-9 pathway may have evolved to ensure effective termination of effector TH1 cells.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
rights and permissionsRights and permissions
Order commercial reprintsOrder commercial reprints
CrossRef lists 49 articles citing this articleCrossRef lists 49 articles citing this article
Save this linkSave this link

Open Innovation Challenges

naturejobs

Competing financial interests
Figures & Tables
Supplementary info
Export citation
natureproducts

Search buyers guide:

 
Nature Immunology
ISSN: 1529-2908
EISSN: 1529-2916
Journal home | Advance online publication | Current issue | Archive | Press releases | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2005 Nature Publishing Group | Privacy policy